Avidus Management Group Inc ASNHF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Avidus Management Group Inc is a Canada based marketer and distributor of nutraceutical products. It is principally engaged in the sales of nutraceuticals and health aids to retail vendors and to individuals or businesses. The company sells its products in the United States and Canada, of which majority of the revenue is generated from the United States.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- http://www.asantae.com
Valuation
|
Metric
|
ASNHF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ASNHF
|
|---|---|
Quick Ratio | 0.02 |
Current Ratio | 0.13 |
Interest Coverage | −9.43 |
Quick Ratio
ASNHF
Profitability
|
Metric
|
ASNHF
|
|---|---|
Return on Assets (Normalized) | −162.12% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ASNHF
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Twkdx | $429.0 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Qyzbxr | $92.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Qhzkf | $91.2 Bil | |
SGEN
| Seagen Inc Ordinary Shares | Bkpgw | $41.2 Bil | |
MRNA
| Moderna Inc | Lrcm | $30.5 Bil | |
ARGX
| argenx SE ADR | Kkqyb | $27.2 Bil | |
BNTX
| BioNTech SE ADR | Xtk | $24.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Yytkvlc | $22.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Xkssjfg | $17.9 Bil | |
INCY
| Incyte Corp | Dbqcg | $12.4 Bil |